New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Further Research Needed to Inform the Management of Post-Chemo Residual Nonretroperitoneal Disease in Testicular Cancer

Further Research Needed to Inform the Management of Post-Chemo Residual Nonretroperitoneal Disease in Testicular Cancer

Teratoma in the primary tumor site was associated with a higher incidence of teratoma in residual nonretroperitoneal (non–RP) disease post-chemotherapy, according to findings from a retrospective stud
World medicine November 09,2023
Further Research Needed to Inform the Management of Post-Chemo Residual Nonretroperitoneal Disease in Testicular Cancer

Further Research Needed to Inform the Management of Post-Chemo Residual Nonretroperitoneal Disease in Testicular Cancer

Teratoma in the primary tumor site was associated with a higher incidence of teratoma in residual nonretroperitoneal (non–RP) disease post-chemotherapy, according to findings from a retrospective stud
World medicine November 09,2023
Depression's heavy toll: Unraveling its impact on overall health in US adults

Depression's heavy toll: Unraveling its impact on overall health in US adults

In a recent study published inJAMA Network Open, researchers assessed the associations between depression and mortality among adults in the United States (US).Depression is prevalent in the US,
World medicine November 09,2023
Depression's heavy toll: Unraveling its impact on overall health in US adults

Depression's heavy toll: Unraveling its impact on overall health in US adults

In a recent study published inJAMA Network Open, researchers assessed the associations between depression and mortality among adults in the United States (US).Depression is prevalent in the US,
World medicine November 09,2023
Do prebiotics and probiotics positively impact cardiovascular and renal health?

Do prebiotics and probiotics positively impact cardiovascular and renal health?

In a recent editorial published in theNutrientsJournal, researchers described the benefits of consuming nutrients, prebiotics, and probiotics to enhance cardiovascular and renal health.Chr
World medicine November 09,2023
Do prebiotics and probiotics positively impact cardiovascular and renal health?

Do prebiotics and probiotics positively impact cardiovascular and renal health?

In a recent editorial published in theNutrientsJournal, researchers described the benefits of consuming nutrients, prebiotics, and probiotics to enhance cardiovascular and renal health.Chr
World medicine November 09,2023
Phase 1 Trial Set to Explore Efficacy and Safety of KB-0742 in Solid Tumors

Phase 1 Trial Set to Explore Efficacy and Safety of KB-0742 in Solid Tumors

Small molecule inhibitors, such as the investigational CDK9 inhibitor KB-0742, are laying the groundwork for continued research into optimal strategies for targeting the biology of solid tumors, accor
World medicine November 09,2023
Phase 1 Trial Set to Explore Efficacy and Safety of KB-0742 in Solid Tumors

Phase 1 Trial Set to Explore Efficacy and Safety of KB-0742 in Solid Tumors

Small molecule inhibitors, such as the investigational CDK9 inhibitor KB-0742, are laying the groundwork for continued research into optimal strategies for targeting the biology of solid tumors, accor
World medicine November 09,2023
Presidential advisory by the American Heart Association: connecting cardiovascular, kidney, and metabolic health

Presidential advisory by the American Heart Association: connecting cardiovascular, kidney, and metabolic health

A recent article published in theCirculationjournal investigated the interplay among chronic kidney disease, metabolic risk factors, and the cardiovascular system on morbidity and mortalit
World medicine November 09,2023
Presidential advisory by the American Heart Association: connecting cardiovascular, kidney, and metabolic health

Presidential advisory by the American Heart Association: connecting cardiovascular, kidney, and metabolic health

A recent article published in theCirculationjournal investigated the interplay among chronic kidney disease, metabolic risk factors, and the cardiovascular system on morbidity and mortalit
World medicine November 09,2023
New AI tool predicts future viral variants using evolutionary, biological information

New AI tool predicts future viral variants using evolutionary, biological information

The COVID-19 pandemic seemed like a never-ending parade of SARS-CoV-2 variants, each equipped with new ways to evade the immune system, leaving the world bracing for what would come next.But what if t
World medicine November 09,2023
New AI tool predicts future viral variants using evolutionary, biological information

New AI tool predicts future viral variants using evolutionary, biological information

The COVID-19 pandemic seemed like a never-ending parade of SARS-CoV-2 variants, each equipped with new ways to evade the immune system, leaving the world bracing for what would come next.But what if t
World medicine November 09,2023
BRAF/EGFR/MEK inhibition suppresses cancer stemness and drug resistance of colorectal cancer cells

BRAF/EGFR/MEK inhibition suppresses cancer stemness and drug resistance of colorectal cancer cells

A new research paper was published inOncotarget'sVolume 14 on October 4, 2023, entitled, "Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colore
World medicine November 09,2023
BRAF/EGFR/MEK inhibition suppresses cancer stemness and drug resistance of colorectal cancer cells

BRAF/EGFR/MEK inhibition suppresses cancer stemness and drug resistance of colorectal cancer cells

A new research paper was published inOncotarget'sVolume 14 on October 4, 2023, entitled, "Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colore
World medicine November 09,2023
Kidney Cancer Study Shows Improved Outcomes for Patients With Advanced Disease When Treated With Belzutifan Over Everolimus

Kidney Cancer Study Shows Improved Outcomes for Patients With Advanced Disease When Treated With Belzutifan Over Everolimus

Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated with immune checkpoint inhibi
World medicine November 09,2023
Kidney Cancer Study Shows Improved Outcomes for Patients With Advanced Disease When Treated With Belzutifan Over Everolimus

Kidney Cancer Study Shows Improved Outcomes for Patients With Advanced Disease When Treated With Belzutifan Over Everolimus

Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated with immune checkpoint inhibi
World medicine November 09,2023
New topical drug shows promise in preventing cutaneous squamous cell carcinoma

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

Cutaneous squamous cell carcinoma is the second most common type of skin cancer in the United States, impacting approximately 700,000 people each year. While medications exist to prevent the developme
World medicine November 09,2023
New topical drug shows promise in preventing cutaneous squamous cell carcinoma

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

Cutaneous squamous cell carcinoma is the second most common type of skin cancer in the United States, impacting approximately 700,000 people each year. While medications exist to prevent the developme
World medicine November 09,2023
AI helps neurosurgeons identify brain tumor types on the spot

AI helps neurosurgeons identify brain tumor types on the spot

What type of brain tumor does this patient have? AI technology helps to determine this as early as during surgery, within 1.5 hours. This process normally takes a week. The new technology allows neuro
World medicine November 09,2023
AI helps neurosurgeons identify brain tumor types on the spot

AI helps neurosurgeons identify brain tumor types on the spot

What type of brain tumor does this patient have? AI technology helps to determine this as early as during surgery, within 1.5 hours. This process normally takes a week. The new technology allows neuro
World medicine November 09,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com